Nivolumab (NSCLC): Injection concentrate for I.V. infusion 40 mg in 4 mL, Injection concentrate for I.V. infusion 100 mg in 10 mL; Opdivo® Page last updated: 14 July 2023 Public Summary Document (PSD) March 2023 PBAC Meeting - (PDF 1.3MB) Public Summary Document (PSD) March 2023 PBAC Meeting - (Word 606KB)